Preemptive oral rofecoxib plus postoperative intraarticular bupivacaine for pain relief after arthroscopic knee surgery

被引:0
作者
Karamanhoglu, Beyhan [1 ]
Alagol, Ayflin [1 ]
Turan, Fatma Nesrin [2 ]
机构
[1] Trakya Univ, Fac Med, Dept Anesthesiol, TR-22030 Edirne, Turkey
[2] Trakya Univ, Fac Med, Dept Biostat, Edirne, Turkey
来源
AGRI-THE JOURNAL OF THE TURKISH SOCIETY OF ALGOLOGY | 2005年 / 17卷 / 02期
关键词
Preemptive; rofecoxib; bupivacaine; postoperative analgesia; arthroscopic knee surgery;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study was designed to test the hypothesis whether preemptive administration of rofecoxib, a novel selective COX-2 inhibitor, can prolong intraarticular bupivacaine analgesia after arthroscopic knee surgery. Sixty-two patients were randomly assigned to one of the three groups. Group 1 (n=21) was administered oral rofecoxib 50 mg 1 h before surgery plus intraarticular 0.5 % bupivacaine 20 ml postoperatively. Group 2 (n=21) was administered the same dose of bupivacaine. Group 3 (n=20) was administered saline 20 ml intraarticularly after surgery. Pain scores (VAS) were assessed at 30 min, 1, 2, 4, 6, 12 and 24 h postoperatively. Analgesia duration, analgesic (tramadol and tenoxicam) requirements, and adverse effects were recorded postoperatively for 24 h. Pain scores were significantly lower in the Group 1 at all time points (p<0.05, p<0.001) and were significantly lower in the Group 2 at 30 min (p<0.001), 1 and 4 h (p<0.05) compared to the Group 3. Pain scores were significantly lower in the Group 1 compared to the Group 2 during the first 4 h after surgery (p<0.05, p<0.001). Analgesia duration was longer in Group 1 than Group 2 or 3 (743.0 +/- 480.5 min versus 262.4 +/- 292.2 min and 17.0 +/- 12.1 min; p<0.05, p<0.001 respectively), and in Group 2 than Group 3 (p<0.05). Tramadol requirements were significantly less in Group 1 than Group 2 and 3 (4.8 +/- 15.0 mg versus 40.5 +/- 43.6 mg and 67.5 +/- 24.5 mg; p<0.05, p<0.001 respectively), and in Group 2 than Group 3 (p<0.05). There were no significant differences among the groups regarding the tenoxicam requirements and adverse effects. In conclusion, the combination of oral rofecoxib administered preemptively and intraarticular bupivacaine administered postoperatively provided a significant analgesic benefit and decreased the opioid requirements after arthroscopic knee surgery, when compared to bupivacaine alone or saline.
引用
收藏
页码:29 / 33
页数:5
相关论文
共 26 条
  • [1] POSTARTHROSCOPY ANALGESIA WITH INTRAARTICULAR BUPIVACAINE MORPHINE - A RANDOMIZED CLINICAL-TRIAL
    ALLEN, GC
    STAMAND, MA
    LUI, ACP
    JOHNSON, DH
    LINDSAY, MP
    [J]. ANESTHESIOLOGY, 1993, 79 (03) : 475 - 480
  • [2] Tramadol or fentanyl analgesia for ambulatory knee arthroscopy
    Cagney, B
    Williams, O
    Jennings, L
    Buggy, D
    [J]. EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 1999, 16 (03) : 182 - 185
  • [3] Chang DJ, 2001, ARTHRITIS RHEUM, V44, pS124
  • [4] CHIRWA S S, 1989, Arthroscopy, V5, P33, DOI 10.1016/0749-8063(89)90087-X
  • [5] Celecoxib - A review of its use in osteoarthritis, rheumatoid arthritis and acute pain
    Clemett, D
    Goa, KL
    [J]. DRUGS, 2000, 59 (04) : 957 - 980
  • [6] NONSTEROIDAL ANTIINFLAMMATORY DRUGS - RATIONALE FOR USE IN SEVERE POSTOPERATIVE PAIN
    DAHL, JB
    KEHLET, H
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 1991, 66 (06) : 703 - 712
  • [7] DAHL MR, 1990, ANESTH ANALG, V71, P670
  • [8] Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model
    Ehrich, EW
    Dallob, A
    De Lepeleire, I
    Van Hecken, A
    Riendeau, D
    Yuan, WY
    Porras, A
    Wittreich, J
    Seibold, JR
    De Schepper, P
    Mehlisch, DR
    Gertz, BJ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (03) : 336 - 347
  • [9] ERIKSSON E, 1986, ORTHOPEDICS, V9, P186
  • [10] COX-2 inhibitors
    Hawkey, CJ
    [J]. LANCET, 1999, 353 (9149) : 307 - 314